Boomfish Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Sell
5,460
-238
-4% -$114K 1.25% 32
2026
Q1
$2.8M Sell
5,698
-10
-0.2% -$5.43K 1.5% 24
2025
Q4
$3.31M Sell
5,708
-493
-8% -$279K 1.77% 14
2025
Q3
$3.01M Buy
6,201
+175
+3% +$81.5K 1.62% 22
2025
Q2
$2.44M Buy
6,026
+1,407
+30% +$588K 1.41% 30
2025
Q1
$2.3M Buy
4,619
+10
+0.2% +$5.42K 1.49% 31
2024
Q4
$2.4M Buy
4,609
+581
+14% +$319K 1.45% 24
2024
Q3
$2.49M Buy
4,028
+26
+0.6% +$15.4K 1.53% 24
2024
Q2
$2.21M Buy
4,002
+159
+4% +$91.1K 1.43% 29
2024
Q1
$2.23M Sell
3,843
-56
-1% -$31.4K 1.5% 29
2023
Q4
$2.07M Buy
+3,899
New +$1.89M 1.49% 30

Other funds holding TMO

Boomfish Wealth Group's TMO Position: Q2 2026 in Review

Boomfish Wealth Group reduced its Thermo Fisher Scientific (TMO) stake by 4.2% in Q2 2026, selling an estimated $114K and leaving 5,460 shares worth $2.74M. The position accounts for 1.25% of the portfolio, ranked #32.

Boomfish Wealth Group first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.31M in Q4 2025. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Boomfish Wealth Group held 5,460 shares of Thermo Fisher Scientific worth $2.74M as of Q2 2026.
  • Boomfish Wealth Group sold 238 Thermo Fisher Scientific shares in Q2 2026, an estimated $114K.
  • Thermo Fisher Scientific made up 1.25% of Boomfish Wealth Group's portfolio in Q2 2026, its #32 holding.
  • Boomfish Wealth Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Boomfish Wealth Group's Thermo Fisher Scientific position peaked at $3.31M in Q4 2025.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Boomfish Wealth Group's 13F filing for Q2 2026, filed 4 Aug 2026.